AETHLON MEDICAL INC (AEMD) Stock Balance Sheet
NASDAQ:AEMD - US00808Y4061 - Common Stock
0.722 USD
-0.01 (-1.65%)
0.72 USD
0 (-0.28%)
| MRQ (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.77M | 5.50M | 5.44M | 14.53M | 17.07M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | 17.07M | |||
| Receivables | N/A | N/A | N/A | 0.00 | 130.00K | |||
| Other Current Assets | 285.70K | 448.50K | 783.80K | 560.00K | 960.00K | |||
| Total Current Assets | 4.05M | 5.95M | 6.23M | 15.09M | 18.16M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.12M | 1.28M | 1.90M | 2.30M | 1.14M | |||
| Intangibles | 400.00 | 600.00 | 1.10K | 0.00 | 0.00 | |||
| Other Non-Current Assets | 131.40K | 131.10K | 120.80K | 120.00K | 120.00K | |||
| Total Non-Current Assets | 1.26M | 1.41M | 2.02M | 2.42M | 1.26M | |||
| TOTAL ASSETS | 5.31M | 7.36M | 8.25M | 17.51M | 19.42M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 127.00K | |||
| Accrued Expenses | 943.20K | 1.19M | 1.05M | 1.07M | 980.00K | |||
| Accounts Payable | 571.50K | 534.50K | 777.90K | 430.00K | 500.00K | |||
| Other Current Liabilities | 112.70K | 178.20K | N/A | 0.00 | 340.00K | |||
| Total Current Liabilities | 1.63M | 1.90M | 1.83M | 1.51M | 1.82M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 255.10K | 336.70K | 649.80K | 940.00K | 600.00K | |||
| Total Non-Current Liabilities | 255.10K | 336.70K | 649.80K | 930.00K | 460.00K | |||
| TOTAL LIABILITIES | 1.88M | 2.24M | 2.48M | 2.44M | 2.28M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -169.72M | -167.95M | -154.57M | -142.36M | -130.33M | |||
| Additional Paid In Capital | 173.16M | 173.09M | 160.34M | 157.41M | 147.45M | |||
| Minority Interest | N/A | N/A | N/A | 0.00 | -140.00K | |||
| Common Shares | 2.60K | 2.60K | 2.60K | 20.00K | 20.00K | |||
| Other Shareholders' Equity | -22.40K | -17.10K | -6.90K | -10.00K | -142.00K | |||
| Shares Outstanding | 2.60M | 2.59M | 328.70K | 287.40K | 192.70K | |||
| Tangible Book Value per Share | 1.32 | 1.98 | 17.54 | 6.55 | 11.12 | |||
| Total Shareholders' Equity | 3.42M | 5.12M | 5.77M | 15.06M | 17.13M | |||
| TOTAL LIABILITIES AND EQUITY | 5.31M | 7.36M | 8.25M | 17.51M | 19.42M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.49 | 3.13 | 3.40 | 9.99 | 9.98 | |||
| Return On Assets (ROA) | -237.06% | -176.64% | -148.05% | -68.76% | -53.66% | |||
| Return On Equity (ROE) | -367.42% | -253.73% | -211.72% | -79.95% | -60.83% | |||
All data in USD , ROIC based on taxRate of 0.21